Join

Live Feed

Delayed 3m

Press · Insider · Buys · Financials

Signed out · 3-min delay · Sign up for real-time

  • Hertz Global Holdings Inc logo
    PR··Consumer Discretionary·
    Hertz Announces Proposed Offering of $300 Million of Exchangeable Senior First-Lien Secured PIK Notes

    Hertz Global Holdings, Inc. (NASDAQ:HTZ) ("Hertz" or the "Company"), a leading global rental car company, today announced that its wholly-owned indirect subsidiary, The Hertz Corporation ("Hertz Corp."), intends to offer, subject to market and other conditions, $300 million in aggregate principal amount of Exchangeable Senior First-Lien Secured PIK Notes due 2030 (the "Notes") in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Hertz Corp. also expects to grant the initial purchasers of the Notes an option to purchase, for settlement within a period of 13 days fro

  • VinFast Auto Ltd. logo
    PR··Industrials·
    As Electric Vehicles Go Mainstream, Trust Becomes the New Differentiator

    IRVINE, Calif., June 24, 2026 /PRNewswire/ -- The global electric vehicle revolution has entered a new phase. For years, the EV conversation centered on range, charging speed and performance. Today, as electric vehicles move from early adopters into the mainstream, a different question is shaping consumer decisions: Who can drivers trust for the long haul? The numbers tell the story. According to the International Energy Agency (IEA), one in four new cars sold worldwide in 2025 was electric. Global EV sales surpassed 20 million units, marking the fifth consecutive year of record growth. Electric vehicles now account for approxi

  • Viking Therapeutics Inc. logo
    PR··Health Care·
    Viking Therapeutics Announces Initiation of Phase 1 Study to Evaluate Novel Amylin Receptor Agonist VK3019 in Healthy Adults

    Single ascending dose study evaluating safety, tolerability, and pharmacokinetics of VK3019Potential to further expand Viking's treatment options for weight lossSAN DIEGO, June 24, 2026 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ:VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced today the initiation of a Phase 1 single ascending dose (SAD) clinical trial of VK3019, an investigational dual amylin and calcitonin receptor agonist (DACRA). VK3019 is being developed as a potential treatment option for weight loss. The study initiation follows the filing and clearance of VK3019's investi

  • MSC Income Fund Inc. logo
    Main Street Capital Corporation logo
    PR··Finance·
    MSC Income Fund Announces Exit of Portfolio Investment

    Generates $11.6 Million Realized Gain from Exit of Equity Investment in Centre Technologies Holdings, LLCHOUSTON, June 24, 2026 /PRNewswire/ -- MSC Income Fund, Inc. (NYSE:MSIF) ("MSC Income" or the "Fund") is pleased to announce that it recently exited its debt investments and equity investment in Centre Technologies Holdings, LLC ("Centre" or the "Company") upon the completion of a majority recapitalization with a new financial sponsor. Founded in 2006 and headquartered in Houston, Texas, Centre is a provider of information technology (IT) services, including managed services, cloud solutions, cyber security, IT consulting and business intelligence (BI) services to lower and middle market

  • REGENXBIO Inc. logo
    PR··Health Care·
    REGENXBIO Completes Dosing in Confirmatory Study of RGX-202, Marking Completion of Registrational Development Program and Supporting Planned BLA Submission in Q3 2026

    Confirmatory study completed ahead of schedule due to strong patient demand and robust investigator interestOn track to initiate BLA in Q3 2026 under the accelerated approval pathway supporting potential approval in 2H 2027ROCKVILLE, Md., June 24, 2026 /PRNewswire/ -- REGENXBIO Inc. (NASDAQ:RGNX) today announced the successful completion of dosing in the confirmatory study of RGX-202, a potential best-in-class gene therapy for Duchenne muscular dystrophy. This milestone positions REGENXBIO to initiate a Biologics License Application (BLA) under the accelerated approval pathway in Q3 2026 for a potential approval by the U.S. Food and Drug Administration (FDA) in the second half of 2027.The BL

  • Venu Holding Corporation logo
    PR··Consumer Discretionary·
    VENU Hosts Intimate FireSuite Investor Event in McKinney, Texas Featuring Three-Time Super Bowl Champion and VENU Shareholder Troy Aikman

    $272 Million in Premium Asset Sales and GrowingVenu Holding Corporation ("VENU" or the "Company") (NYSE:VENU), an owner, operator, and developer of premium live entertainment destinations, today announced that it hosted a private investor event just north of Dallas, in McKinney, Texas, featuring NFL Hall of Famer, three-time Super Bowl Champion, national spokesperson, and VENU® shareholder Troy Aikman.This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260624144272/en/VENU Hosts Intimate FireSuite Investor Event in McKinney, Texas Featuring Three-Time Super Bowl Champion and VENU Shareholder Troy AikmanThe event took place this past Mo

  • OrthoPediatrics Corp. logo
    PR··Health Care·
    OrthoPediatrics Announces Distribution Agreement with OSSIO, Inc. to Provide Revolutionary Orthopedic Fixation Technology to U.S. Children’s Hospitals Nationwide

    WARSAW, Ind., June 24, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced an exclusive distribution agreement with OSSIO, Inc. ("OSSIO") that brings U.S. children’s hospitals nationwide a bio-integrative, metal-free fixation technology ideally suited for treatment of fractures and deformities in pediatric patients. After performing their fixation function, OSSIOfiber® implants are gradually replaced by the patient’s newly formed bone during the natural healing process. This technological advance in material science decreases the need for hardware r

  • Teledyne Technologies Incorporated logo
    PR··Industrials·
    Teledyne FLIR Defense Awarded $28.8 Million Contract by U.S. Customs and Border Protection for Mobile Surveillance Systems

    Will deliver its LVSS vehicle-based platform for the Enhanced Mobile Surveillance Capability-Lite program to secure U.S. borders Teledyne Technologies Incorporated (NYSE:TDY) announced that Teledyne FLIR Defense has won a $28.8 million contract from U.S. Customs and Border Protection (CBP), an agency of the U.S. Department of Homeland Security, to support the agency’s Enhanced Mobile Surveillance Capability–Lite (eMSC-L) program to bolster border security operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260624478803/en/Teledyne FLIR Defense has won a $28.8 million contract from U.S. Customs and Border Protection, an

  • CalciMedica Inc. logo
    PR··Health Care·
    CalciMedica Announces Private Placement Financing for Up to Approximately $49 Million to Advance Pulmonary Hypertension Program

    Proceeds expected to support a focused pulmonary hypertension strategy, including a Phase 1b proof-of-concept study evaluating Auxora™ in PAH, with data anticipated mid-2027, and advancement of oral CRAC channel inhibitor CM5480 to IND clearance expected mid-2027Anticipated cash runway into 2H 2027 with upfront proceedsLA JOLLA, Calif., June 24, 2026 /PRNewswire/ -- CalciMedica, Inc. ("CalciMedica" or the "Company") (NASDAQ:CALC), a clinical-stage biopharmaceutical company developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for serious inflammatory, immunologic, and cardiopulmonary diseases, today announced it has entered into a definitive securities purcha

  • Iridium Communications Inc logo
    PR··Telecommunications·
    Iridium NTN Direct Begins Live Testing with Mlink

    Mlink chipsets expand the ecosystem for Iridium's standards-based NB-IoT and D2D connectivity MCLEAN, Va., June 24, 2026 /PRNewswire/ -- Iridium Communications Inc. (NASDAQ:IRDM), a leading provider of global voice, data, and positioning, navigation, and timing (PNT) satellite services, today announced that Mlink Technology Inc. (Mlink), a leading fabless semiconductor company specializing in IoT and satellite communication chipsets, has begun live, on-air testing of its MS150-IR IoT-NTN chipset using Iridium NTN Direct℠. MS150-IR is a specialized version of the MS150 chipset family, developed specifically for Iridium NTN Direct as part of Mlink's global IoT-NTN product portfolio.

  • Phio Pharmaceuticals Corp. logo
    PR··Health Care·
    Phio Pharmaceuticals Reaches Key Milestone in Advancing Lead Candidate PH-762

    Nitto Denko Avecia begins first commercial-scale cGMP production of PH-762 drug substanceNewly manufactured supply will support upcoming clinical trial in next development phaseKing of Prussia, Pennsylvania--(Newsfile Corp. - June 24, 2026) - Phio Pharmaceuticals Corp. (NASDAQ:PHIO), a clinical-stage siRNA biopharmaceutical company focused on developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer, today announced that the manufacture of the first commercial-scale cGMP batch of PH-762 drug substance has commenced at Nitto Denko Avecia, Inc. Phio entered into a comprehensive drug substance services agreement with Nitto Denko Avecia, Inc. in June 2

  • Pulsenmore Ltd. logo
    PR··Health Care·
    Pulsenmore Announces Strategic Partnership with Ouma Health to Expand Access to Remote Prenatal Care Across the United States

    FDA-authorized home ultrasound technology to be integrated into Ouma Health's virtual maternity care model, creating a scalable pathway to expand the adoption of home ultrasound in prenatal care across the United StatesRAMAT GAN, Israel, June 24, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ:PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced a strategic partnership with Ouma Health, a leading provider of virtual maternity care solutions in the United States. Through the collaboration, Ouma Health will incorporate Pulsenmore's FDA-authorized home ultrasou

  • CalciMedica Inc. logo
    PR··Health Care·
    CalciMedica Announces Clinical Development of Auxora May Proceed Following FDA Review of KOURAGE Trial Interim Safety Data

    FDA reviewed a protocol amendment and interim safety data from the KOURAGE trial evaluating Auxora in AKI patientsNo comments or questions were receivedConfirms CalciMedica's ability to continue clinical development of Auxora across indicationsLA JOLLA, Calif., June 24, 2026 /PRNewswire/ -- CalciMedica, Inc. ("CalciMedica" or the "Company") (NASDAQ:CALC), a clinical-stage biopharmaceutical company developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for serious inflammatory, immunologic, and cardiopulmonary diseases, today announced that the U.S. Food and Drug Administration (FDA) has reviewed a protocol amendment and interim safety data for CalciMedica's Ph

  • Main Street Capital Corporation logo
    PR··Finance·
    Main Street Announces Exit of Portfolio Investment

    Generates $46.4 Million Realized Gain from Exit of Equity Investment in Centre Technologies Holdings, LLCHOUSTON, June 24, 2026 /PRNewswire/ -- Main Street Capital Corporation (NYSE:MAIN) ("Main Street") is pleased to announce that it recently exited its debt investments and equity investment in Centre Technologies Holdings, LLC ("Centre" or the "Company") upon the completion of a majority recapitalization with a new financial sponsor. Founded in 2006 and headquartered in Houston, Texas, Centre is a provider of information technology (IT) services, including managed services, cloud solutions, cyber security, IT consulting and business intelligence (BI) services to lower and middle market bus

  • Canadian Solar Inc. logo
    PR··Technology·
    Canadian Solar Achieves Silver Certification Under SSI Supply Chain Traceability for Ingot and Cell Production

    KITCHENER, ON, June 24, 2026 /PRNewswire/ -- Canadian Solar Inc. (the "Company" or "Canadian Solar") (NASDAQ:CSIQ) today announced that its Baotou ingot manufacturing facility and Suqian solar cell manufacturing facility achieved the Silver Level Solar Stewardship Initiative (SSI) Supply Chain Traceability Certification. Canadian Solar is the first manufacturer to achieve Silver certification under the SSI Supply Chain Traceability Certification for both ingot and cell production. This certification demonstrates the Company's commitment to transparency and traceability across its upstream suppliers and to advancing responsible sourcing. The SSI Supply Chain Traceability Standard is designed

  • Canadian Solar Inc. logo
    PR··Technology·
    e-STORAGE to Supply 381 MWh Battery Storage System for Apex Clean Energy in Michigan

    KITCHENER, ON, June 24, 2026 /PRNewswire/ -- Canadian Solar Inc. (the "Company" or "Canadian Solar") (NASDAQ:CSIQ) today announced that e-STORAGE, its energy storage solutions business, will supply a 75 MW / 381 MWh DC battery energy storage system (BESS) to Apex Clean Energy in Branch County, Michigan. The system will be co-located with Apex's operating Coldwater Solar facility. Under the agreement, e-STORAGE will deliver a complete, integrated solution that combines SolBank 3.0 battery blocks with Power Conversion Systems and e-STORAGE's proprietary EQ‑S Energy Management System into one coordinated utility‑scale platform. Deliveries are scheduled to begin in early 2027, with commercial op

  • Garmin Ltd. logo
    PR··Industrials·
    Garmin Ltd. schedules second quarter 2026 earnings call

    SCHAFFHAUSEN, Switzerland, June 24, 2026 /PRNewswire/ -- Garmin Ltd. (NYSE:GRMN) invites shareholders and investors to listen to its second quarter 2026 earnings conference call on Wednesday, July 29, 2026, at 10:30 a.m. EDT, with executives of Garmin. The call will be held in conjunction with the company's earnings release, which will be distributed prior to market open on July 29, 2026. The conference call can be accessed by registering online at GRMN Q2 2026 Earnings Call Webcast, at which time registrants will receive dial-in information as well as a conference ID.The live webcast will be accessible from the Garmin Ltd. inv

  • Nebius Group N.V. logo
    PR··Technology·
    Nebius AI Cloud 3.6 strengthens developer experience and governance for production operations

    Developer enhancements include Nebius Echo agent for controlling infrastructure, alongside a smoother day-to-day console experience New enterprise security and governance controls support sensitive workloads in regulated environments Nebius opens Nebius Builder Program in early preview and launches Nebius Certifications to give AI cloud professionals validated, verifiable credentials Nebius today unveiled Nebius AI Cloud 3.6, adding new developer experience, security and governance improvements, as well as enhanced storage capabilities for teams running AI in production on Nebius’s full-stack AI cloud platform. Version 3.6 of Nebius AI Cloud "Aether" introduces Nebius Echo, a fi